Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

被引:0
|
作者
Pedro Marques
Sayka Barry
Eivind Carlsen
David Collier
Amy Ronaldson
Sherine Awad
Neil Dorward
Joan Grieve
Nigel Mendoza
Samiul Muquit
Ashley B. Grossman
Frances Balkwill
Márta Korbonits
机构
[1] Queen Mary University of London,Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry
[2] STHF,Department of Pathology
[3] The National Hospital for Neurology and Neurosurgery,Department of Neurosurgery
[4] UCLH,Department of Neurosurgery
[5] NHS Trust,Barts Cancer Institute, Barts and the London School of Medicine and Dentistry
[6] Charing Cross Hospital,undefined
[7] Imperial College,undefined
[8] Derriford Hospital,undefined
[9] Queen Mary University of London,undefined
关键词
Pituitary neuroendocrine tumour; Pituitary adenoma; Tumour microenvironment; Cytokine; Chemokine; Immune cell; Macrophages; Lymphocytes; Neutrophils; Epithelial-to-mesenchymal transition;
D O I
暂无
中图分类号
学科分类号
摘要
Non-tumoural cells within the tumour microenvironment (TME) influence tumour proliferation, invasiveness and angiogenesis. Little is known about TME in pituitary neuroendocrine tumours (PitNETs). We aimed to characterise the role of TME in the aggressive behaviour of PitNETs, focusing on immune cells and cytokines. The cytokine secretome of 16 clinically non-functioning PitNETs (NF-PitNETs) and 8 somatotropinomas was assessed in primary culture using an immunoassay panel with 42 cytokines. This was correlated with macrophage (CD68, HLA-DR, CD163), T-lymphocyte (CD8, CD4, FOXP3), B-lymphocyte (CD20), neutrophil (neutrophil elastase) and endothelial cells (CD31) content, compared to normal pituitaries (NPs, n = 5). In vitro tumour–macrophage interactions were assessed by conditioned medium (CM) of GH3 (pituitary tumour) and RAW264.7 (macrophage) cell lines on morphology, migration/invasion, epithelial-to-mesenchymal transition and cytokine secretion. IL-8, CCL2, CCL3, CCL4, CXCL10, CCL22 and CXCL1 are the main PitNET-derived cytokines. PitNETs with increased macrophage and neutrophil content had higher IL-8, CCL2, CCL3, CCL4 and CXCL1 levels. CD8+ T-lymphocytes were associated to higher CCL2, CCL4 and VEGF-A levels. PitNETs had more macrophages than NPs (p < 0.001), with a 3-fold increased CD163:HLA-DR macrophage ratio. PitNETs contained more CD4+ T-lymphocytes (p = 0.005), but fewer neutrophils (p = 0.047) with a 2-fold decreased CD8:CD4 ratio. NF-PitNETs secreted more cytokines and had 9 times more neutrophils than somatotropinomas (p = 0.002). PitNETs with higher Ki-67 had more FOXP3+ T cells, as well as lower CD68:FOXP3, CD8:CD4 and CD8:FOXP3 ratios. PitNETs with “deleterious immune phenotype” (CD68hiCD4hiFOXP3hiCD20hi) had a Ki-67 ≥ 3%. CD163:HLA-DR macrophage ratio was positively correlated with microvessel density (p = 0.015) and area (p < 0.001). GH3 cell-CM increased macrophage chemotaxis, while macrophage-CM changed morphology, invasion, epithelial-to-mesenchymal transition and secreted cytokines of GH3 cells. PitNETs are characterised by increased CD163:HLA-DR macrophage and reduced CD8:CD4 and CD8:FOXP3 T cell ratios. PitNET-derived chemokines facilitate macrophage, neutrophil and T cell recruitment into the tumours which can determine aggressive behaviour.
引用
收藏
相关论文
共 50 条
  • [31] Molecular characterization of the tumour microenvironment in neuroendocrine malignancy.
    Pinato, David James
    Vallipuram, Anu
    Evans, Joanne
    Wong, Clement
    Zhang, Hua
    Brown, Matthew
    Dina, Roberto
    Trivedi, Pritesh
    Akarca, Ayse
    Marafioti, Teresa
    Mauri, Francesco A.
    Sharma, Rohini
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Primary Pituitary Carcinoids Do Not Exist: A Reappraisal in the Era of Pituitary Neuroendocrine Tumours
    Armeni, Eleni
    Alexandraki, Krystallenia I.
    Roncaroli, Federico
    Grossman, Ashley B.
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (08)
  • [33] MGMT expression and pituitary tumours: relationship to tumour biology
    Ann McCormack
    Warren Kaplan
    Anthony J. Gill
    Nicholas Little
    Raymond Cook
    Bruce Robinson
    Roderick Clifton-Bligh
    Pituitary, 2013, 16 : 208 - 219
  • [34] MGMT expression and pituitary tumours: relationship to tumour biology
    McCormack, Ann
    Kaplan, Warren
    Gill, Anthony J.
    Little, Nicholas
    Cook, Raymond
    Robinson, Bruce
    Clifton-Bligh, Roderick
    PITUITARY, 2013, 16 (02) : 208 - 219
  • [35] Tumour suppressor genes in the pathogenesis of human pituitary tumours
    Clayton, RN
    Boggild, M
    Bates, AS
    Bicknell, J
    Simpson, D
    Farrell, W
    HORMONE RESEARCH, 1997, 47 (4-6) : 185 - 193
  • [36] Pituitary stalk metastasis of a neuroendocrine tumour of unknown origin
    Kluczynski, Lukasz
    Morawiec-Slawek, Karolina
    Pantoflinski, Jacek
    Opalinska, Marta
    Sowa-Staszczak, Anna
    Grochowska, Anna
    Gilis-Januszewska, Aleksandra
    Hubalewska-Dydejczyk, Alicja
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (06) : 992 - 993
  • [37] Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification
    Dottermusch, Matthias
    Schueller, Ulrich
    Hagel, Christian
    Saeger, Wolfgang
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (01)
  • [38] Discovery of novel miRNA markers for pituitary neuroendocrine tumour
    Niedra, Helvijs
    Peculis, Raitis
    Konrade, Ilze
    Balcere, Inga
    Romanovs, Mihails
    Steina, Liva
    Stukens, Janis
    Sokolovska, Jelizaveta
    Klovins, Janis
    Rovite, Vita
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 148 - 148
  • [39] Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
    Gilabert-Oriol, Roger
    Ryan, Gemma M.
    Leung, Ada W. Y.
    Firmino, Natalie S.
    Bennewith, Kevin L.
    Bally, Marcel B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [40] Tumour microenvironment: informing on minimal residual disease in solid tumours
    Pantel, Klaus
    Alix-Panabieres, Catherine
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (06) : 325 - 326